Peter Farha

535 total citations
15 papers, 442 citations indexed

About

Peter Farha is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Peter Farha has authored 15 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Peter Farha's work include Lung Cancer Research Studies (8 papers), Lung Cancer Treatments and Mutations (6 papers) and Neuroendocrine Tumor Research Advances (3 papers). Peter Farha is often cited by papers focused on Lung Cancer Research Studies (8 papers), Lung Cancer Treatments and Mutations (6 papers) and Neuroendocrine Tumor Research Advances (3 papers). Peter Farha collaborates with scholars based in United States and United Kingdom. Peter Farha's co-authors include Manuel Valdivieso, Gary Spitzer, Hari M. Dhingra, William K. Murphy, Delia F. Chiuten, Theera Umsawasdi, David Carr, Daniel J. Booser, H. Thomas Barkley and Tseng-hui Timothy Chen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Peter Farha

14 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Farha United States 9 340 272 115 81 43 15 442
C. Grafton Canada 9 349 1.0× 242 0.9× 217 1.9× 141 1.7× 50 1.2× 18 531
Swee‐Peng Yap Singapore 7 287 0.8× 255 0.9× 80 0.7× 100 1.2× 59 1.4× 9 532
Haruhito Kamei Japan 9 389 1.1× 465 1.7× 53 0.5× 53 0.7× 66 1.5× 37 573
M.C. Berchier Belgium 14 363 1.1× 281 1.0× 161 1.4× 132 1.6× 20 0.5× 26 479
D. Dodwell United Kingdom 10 249 0.7× 105 0.4× 36 0.3× 67 0.8× 95 2.2× 14 393
Caron Modeas United States 9 190 0.6× 355 1.3× 23 0.2× 37 0.5× 28 0.7× 12 399
M Dukeman United States 7 252 0.7× 360 1.3× 34 0.3× 99 1.2× 224 5.2× 8 513
Xanthi Tsiafaki Greece 11 598 1.8× 571 2.1× 137 1.2× 161 2.0× 42 1.0× 36 762
Takahisa Kawamura Japan 18 571 1.7× 673 2.5× 107 0.9× 141 1.7× 50 1.2× 64 893
Michael Korn United States 10 166 0.5× 62 0.2× 55 0.5× 57 0.7× 52 1.2× 18 256

Countries citing papers authored by Peter Farha

Since Specialization
Citations

This map shows the geographic impact of Peter Farha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Farha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Farha more than expected).

Fields of papers citing papers by Peter Farha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Farha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Farha. The network helps show where Peter Farha may publish in the future.

Co-authorship network of co-authors of Peter Farha

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Farha. A scholar is included among the top collaborators of Peter Farha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Farha. Peter Farha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Umsawasdi, Theera, Manuel Valdivieso, Daniel J. Booser, et al.. (1989). Weekly doxorubicinversus doxorubicin every 3 weeks in cyclophosphamide, doxorubicin, and cisplatin chemotherapy for non-small cell lung cancer. Cancer. 64(10). 1995–2000. 18 indexed citations
3.
Laberge, Francis, Herbert A. Fritsche, Theera Umsawasdi, et al.. (1987). Use of carcinoembryonic antigen in small cell lung cancer prognostic value and relation to the clinical course 1. Cancer. 59(12). 2047–2052. 25 indexed citations
4.
Spitzer, Gary, et al.. (1986). I.v. melphalan in carcinoma of the lung: effect of cyclophosphamide priming on hematopoietic toxicity.. PubMed. 70(4). 449–53. 4 indexed citations
5.
Spitzer, Gary, Peter Farha, Manuel Valdivieso, et al.. (1986). High-dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinoma.. Journal of Clinical Oncology. 4(1). 4–13. 72 indexed citations
6.
Dhingra, Hari M., Manuel Valdivieso, David Carr, et al.. (1985). Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer.. Journal of Clinical Oncology. 3(2). 176–183. 67 indexed citations
7.
Umsawasdi, Theera, Manuel Valdivieso, H. Thomas Barkley, et al.. (1985). Esophageal complications from combined chemoradiotherapy (cyclophosphamide + adriamycin + cisplatin + xrt) in the treatment of non-small cell lung cancer. International Journal of Radiation Oncology*Biology*Physics. 11(3). 511–519. 34 indexed citations
8.
Kalter, S. S., Hari M. Dhingra, & Peter Farha. (1985). Primary Therapy for Small Cell Lung Cancer Reversing the Eaton-Lambert Syndrome. Southern Medical Journal. 78(2). 197–198. 5 indexed citations
9.
Valdivieso, Manuel, Peter Farha, Gary Spitzer, et al.. (1984). Increasing importance of adjuvant surgery in inoperable lung cancer.. PubMed. 80(8). 38–42. 2 indexed citations
10.
Umsawasdi, Theera, Manuel Valdivieso, Tseng-hui Timothy Chen, et al.. (1984). Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer. Journal of Neuro-Oncology. 2(3). 253–259. 106 indexed citations
11.
Dhingra, Hari M., Manuel Valdivieso, Daniel J. Booser, et al.. (1984). Chemotherapy for advanced adenocarcinoma and squamous cell carcinoma of the lung with etoposide and cisplatin.. PubMed. 68(4). 671–3. 13 indexed citations
12.
Kantarjian, Hagop M., Peter Farha, Gary Spitzer, William K. Murphy, & Manuel Valdivieso. (1984). Systemic Combination Chemotherapy as Primary Treatment of Brain Metastasis From Lung Cancer. Southern Medical Journal. 77(4). 426–430. 33 indexed citations
13.
Farha, Peter, Gary Spitzer, Manuel Valdivieso, et al.. (1983). High-dose chemotherapy and autologous bone marrow transplantation for the treatment of small cell lung carcinoma. Cancer. 52(8). 1351–1355. 49 indexed citations
14.
Valdivieso, Manuel, Peter Farha, Theera Umsawasdi, et al.. (1982). Antineoplastic Chemotherapy of Advanced Lung Cancer. Seminars in Respiratory and Critical Care Medicine. 4(1). 28–41. 6 indexed citations
15.
Bernardino, Michael E., et al.. (1982). Computed Tomography and Routine Chest Radiography in Oat Cell Carcinoma of the Lung. Journal of Computer Assisted Tomography. 6(4). 739–745. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026